Analysis of proliferating cell nuclear antigen expression in 24 cases of primary non-small cell lung cancer and correlation with survival;Análisis de la expresión del antígeno nuclear de proliferatión celular (PCNA) en 24 carcinomas primarios de pulmón de células no pequeñas y correlación con la supervivencia

Archivos de Bronconeumologia

Volumn 32, Issue 3, 1996, Pages 127-131

  Castellano, V M ^a   Sotelo, T ^a   Ballestin C ^a   Lopez Encuentra A ^a   Varela, G ^a  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

Author keywords

Cyclin; Immunohistochemistry; Lung cancer; PCNA; Prognostic factor; Proliferating cell nuclear antigen; Survival

Indexed keywords

CYCLINE;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; COMPARATIVE STUDY; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; LUNG NON SMALL CELL CANCER; LUNG TUMOR; MALE; MIDDLE AGED; MORTALITY; PROGNOSIS; SQUAMOUS CELL CARCINOMA; TIME;

ADENOCARCINOMA; ADULT; AGED; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; PROLIFERATING CELL NUCLEAR ANTIGEN; TIME FACTORS;

EID: 0030094439     PISSN: 03002896     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-2896(15)30798-5     Document Type: Article

References (31)

1. Miyachi K, Fritzler MJ, Tan EM. An autoantibody to a nuclear antigen in proliferating cells. J Immunol 1978; 121: 2.228-2.234.
2. Bravo R, Celis JE. A search for differential polypeptide synthesis throughout the cell cycle of Hela cells. J Cell Biol 1980; 84: 795-802.
3. Mathews MB, Bernstein RM, Franza BR, Garrels JI. The identity of the proliferating cell nuclear antigen and cyclin. Nature 1984; 309: 374-376.
4. Takasaki Y, Fischwild D, Tan EM. Characterization of proliferating cell nuclear antigen recognized by autoantibodies in lupus sera. J Exp Med 1984; 159: 981-992.
5. Celis JE, Celis A. Cell cycle dependent variations in the distribution of the nuclear antigen in cultured cells: subdivision of S phase. Proc Natl Acad Sci USA 1985; 82: 143-157.
6. Jaskulski D, De Riel JK, Mercer WE, Calabretta B, Baserga R. Inhibition of cellular proliferation by antisence oligodeoxynucleotides to PCNA cyclin. Science 1988; 240: 1.544-1.546.
7. Zuber M, Tan EM, Ryoji M. Involvement of proliferating cell nuclear antigen (cyclin) in DNA replication in living cells. Mol Cell Biol 1989; 9:57-66.
8. Tan CK, Castillo C, So AG, Downey KM. An auxiliary protein for DNA polymerase-delta from foetal calf thymus. J Biol Chem 1986; 261: 12.310-12.316.
9. Bravo R, Frank R, Blundell PA, MacDonald-Bravo H. Cyclin/PCNA is the auxiliary protein of DNA polymerase-delta. Nature 1987; 326: 515-517.
10. Prelich G, Tan CK, Kostura M, Mathews MB, So Ag, Downey KM, Stillman B. Functional identity of proliferating cell nuclear antigen and a DNA polymerase-delta auxilliary protein. Nature 1987; 326: 517-520.
11. Robbins BA, De la Vega D, Ogata K, Tan EM, Nakamura R. Immunohistochemical detection of proliferating cell nuclear antigen in solid human malignances. Arch Pathol Lab Med 1987; 111: 841-845.
12. Hall PA, Levison DA, Woods AL, Yu CCW, Kelloek DB, Watkins JA, Bames DM, Gillet CE, Camplejohn R, Dorel R, Waseen NH, Lane DP. Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: an index of cell proliferation with evidence of deregulated expression in some neoplasms. J Pathol 1990; 162: 285-294.
13. Theunissen PHMH, Leers MPG, Bollen ECM. Proliferating cell nuclear antigen (PCNA) expresion in formalin-fixed tissue of non-small cell lung carcinoma. Histopathology 1992; 20: 251-255.
14. Carey FA, Fabbroni G, Lamb D. Expression of proliferating cell nuclear antigen in lung cancer: a systematic study and correlation with DNA ploidy. Histopathology 1992; 20: 499-503.
15. Fontanini G, Macchiarini P, Pepe S, Ruggiero A, Hardin MJ, Bigini D, Vignati S, Pingitore R, Ageletti CA. The expression of proliferating cell nuclear antigen in paraffin sections of peripheral, node-negative non-small cell lung cancer. Cancer 1992; 70: 1.520-1.527.
16. Macchiarini P, Fontanini G, Hardin MJ, Chuanchich H, Bigini D, Vignati S, Pingitore R, Angeletti A. Blood vessel invasion by tumor cells predicts recurrence in completely resected TI NO MO non-small-cell lung cancer. J Thorac Cardiovasc Surg 199; 106: 80-89.
17. Ogawa JI, Tsurumi T, Yamada S, Koide S, Shohtsu A. Blood vessel invasion and expression of sialyl Lewis and proliferating cell nuclear antigen in stage I non-small cell lung cancer. Cancer 1994; 73: 1.177-1.183.
18. Ogawa JI, Iwazaki M, Inoue H, Koide S, Shohtsu A. Immunohistochemical study of glutatione-related enzymes and proliferative antigens in lung cancer. Relation to cisplatin sensitivity. Cancer 1993; 71: 2.204-2.209.
19. Garcia RL, Coltrera MD, Gown AM. Analysis of proliferative grade using anti-PCNA/cyclin monoclonal antibodies in fixed, embedded tissues. Am J Pathol 1989; 134: 733-739.
20. Fujii M, Motoi M, Saeki H, Aoe K, Moriwaki S. Prognostic significance of proliferating cell nuclear antigen (PCNA) expression in non-small cell lung cancer. Acta Med Okayama 1993; 4: 103-108.
21. Ebina M, Steinberg SM, Mulshine JL, Linnoila RI. Relationship of p53 overexpression and up-regulation of proliferating cell nuclear antigen with the clinical course of non-small cell lung cancer. Cancer Res 1994; 54: 2.496-2.503.
22. Ishida T, Kaneko S, Akazawa K, Tateishi M, Sugio K, Sugimachi K. Proliferating cell nuclear antigen expression and argyrophilic nucleolar organizer regions as factors influencing prognosis of surgically treated lung cancer patients. Cancer Res 1993; 53: 5.000-5.003.
23. Fontanini G, Vignati S, Bigini D, Merlo GR, Ribecchini A, Angeletti CA et al. Human non-small cell lung cancer: p53 protein acumulation is an early event and persists during metastatic progression. J Pathol 1994; 174: 23-31.
24. Kawai T, Suzuki M, Kono S, Shinomiya N, Rokutanda M, Tagaki K et al. Proliferating cell nuclear antigen and Ki-67 in lung carcinoma. Correlation with DNA flow cytometric analysis. Cancer 1994; 74: 2.468-2.475.
25. Bravo R, MacDonald-Bravo H. Existence of two populations of cyclin/proliferating cell nuclear antigen during the cell cycle: association with DNA replication sites. J Cell Biol 1987; 105: 1.549-1.554.
26. Chang CD, Ottavio L, Travalli S, Lipson Ke, Baserga R. Transcriptional and posttranscriptional regulation of mRNA levels of the proliferating cell nuclear antigen gene. Mol Cell Biol 1990; 10: 3.289-3.296.
27. Almendral JM, Huebsch D, Blundell PA, MacDonald-Bravo H, Bravo R. Cloning and sequence of the human nuclear protein cyclin: homology with DNA binding proteins. Proc Natl Acad Sci USA 1987; 84: 1.575-1.579.
28. Waseem NH, Lane DP. Monoclonal antibody analysis of the proliferating cell nuclear antigen (PCNA). Structural conservation and the detection of a nucleolar form. J Cell Sci 1990; 96: 121-129.
29. Ogata K, Kurki P, Celis JE, Nakamura RM, Tan EM. Monoclonal antibodies to a nuclear protein (PCNA/cyclin) associated with DNA replication. Exp Cell Res 1987; 168: 475-486.
30. Woods AL, Hall PA, Shepherd NA, Handy AM, Weseem NH, Lane DP et al. The assessment of proliferating cell nuclear antigen (PCNA) immunostaning in primary gastrointestinal Iymphomas and its relationship to histological grade, S+G2+M phase fraction (flow cytometric analysis) and prognosis. Histopathology 1991; 19: 21-27.
31. Yu CCW, Hall PA, Fletcher CDM, Camplejohn RS, Weseem NH, Lane DP et al. Haemangiopericytoma: the prognostic value of immunohistochemical staining with a monoclonal antibody to proliferating cell nuclear antigen (PCNA). Histopathology 1991; 19: 29-23.